BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2723122)

  • 1. Bioavailability of citrate from two different preparations of potassium citrate.
    Harvey JA; Zobitz MM; Pak CY
    J Clin Pharmacol; 1989 Apr; 29(4):338-41. PubMed ID: 2723122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
    Koenig K; Padalino P; Alexandrides G; Pak CY
    J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of Urocit-K: a slow releasing potassium citrate].
    Hwang TI; Yang CR; Lai LH
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Mar; 49(3):194-8. PubMed ID: 1316212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Gonzalez G; Taylor R; Wuermser LA; Pak CY
    Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of renal citrate excretion by oral potassium citrate administration: time course, dose frequency schedule, and dose-response relationship.
    Pak CY; Skurla C; Brinkley L; Sakhaee K
    J Clin Pharmacol; 1984 Jan; 24(1):19-26. PubMed ID: 6707230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal citrate absorption in nephrolithiasis.
    Fegan J; Khan R; Poindexter J; Pak CY
    J Urol; 1992 May; 147(5):1212-4. PubMed ID: 1569651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior calcium bioavailability of effervescent potassium calcium citrate over tablet formulation of calcium citrate after Roux-en-Y gastric bypass.
    Sakhaee K; Pak C
    Surg Obes Relat Dis; 2013; 9(5):743-8. PubMed ID: 22222299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citraturic response to oral citric acid load.
    Sakhaee K; Alpern R; Poindexter J; Pak CY
    J Urol; 1992 Apr; 147(4):975-6. PubMed ID: 1552616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium bioavailability from magnesium citrate and magnesium oxide.
    Lindberg JS; Zobitz MM; Poindexter JR; Pak CY
    J Am Coll Nutr; 1990 Feb; 9(1):48-55. PubMed ID: 2407766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of meal on the physiological and physicochemical actions of potassium citrate.
    Pak CY; Oh MS; Baker S; Morris JS
    J Urol; 1991 Sep; 146(3):803-5. PubMed ID: 1875495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.
    Nicar MJ; Peterson R; Pak CY
    J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
    Berg C; Larsson L; Tiselius HG
    J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia.
    Wuermser LA; Reilly C; Poindexter JR; Sakhaee K; Pak CY
    Kidney Int; 2000 Feb; 57(2):607-12. PubMed ID: 10652038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of various potassium salts on renal citrate excretion.
    Sakhaee K; Alpern R; Jacobson HR; Pak CY
    J Clin Endocrinol Metab; 1991 Feb; 72(2):396-400. PubMed ID: 1899422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sodium citrate and oral potassium citrate on urease-induced crystallization.
    Wang YH; Grenabo L; Hedelin H; Pettersson S
    Br J Urol; 1994 Oct; 74(4):409-15. PubMed ID: 7820416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
    Pak CY; Fuller C
    Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
    Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
    Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of orange juice consumption on urinary stone risk factors.
    Wabner CL; Pak CY
    J Urol; 1993 Jun; 149(6):1405-8. PubMed ID: 8501777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.